Evidence map›Paper›PMID 40387330›Full record

ArticleMicrobiology spectrum2025

Highly carbapenem-resistant

Maiko Kirikae, Satoshi Oshiro, Satomi Takei, Naeko Mizutani, Atsuo Itakura, Pan Ei Soe, Thi Thi Htoon, Swe Setk, Htay Htay Tin, Teruo Kirikae and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Biomedical reports · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maiko KirikaeDepartment of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Satoshi OshiroJuntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
Satomi TakeiDepartment of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Naeko MizutaniJuntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
Atsuo ItakuraDepartment of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Pan Ei SoeNational Health Laboratory, Yangon, Myanmar.
Thi Thi HtoonNational Health Laboratory, Yangon, Myanmar.
Swe SetkNational Health Laboratory, Yangon, Myanmar.
Htay Htay TinNational Health Laboratory, Yangon, Myanmar.
Teruo KirikaeJuntendo Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
Tatsuya TadaDepartment of Microbiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-3053-1879

Funding

Japan Agency for Medical Research and Development 25jm0110026h0004Japan Society for the Promotion of Science 21K07031Japan Society for the Promotion of Science 24K10204
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Achromobacter denitrificansAnti-Bacterial Agentsbeta-LactamasesCarbapenemsDrug Resistance, Multiple, BacterialGram-Negative Bacterial InfectionsBacterial ProteinsHumansMaleMicrobial Sensitivity TestsMyanmarWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesCarbapenemsAchromobacter xylosoxidansblaNDM-1carbapenemasemultidrug resistance

Identifiers

PMID40387330
PMCPMC12210851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.